Elisabetta Barresi

A diagnostic trap for the dermatopathologist: granulomatous reactions from cutaneous microimplants for cosmetic purposes

We present a case of late granulomatous reactions from silicone that first appeared in a site different from that of the injection causing an incorrect diagnosis of liposarcoma in the beginning. The histological picture was a cystic‐macrophagic granuloma in both the injection site (upper lip) and the migrating site (paranasal regions). We think that the foreign body has undergone an antigravity migration from the upper lip to the right paranasal region. To our knowledge, such a phenomenon has not been yet reported in literature.

Biological aggressiveness evaluation in prostate carcinomas: immunohistochemical analysis of PCNA and p53 in a series of Gleason 6 (3+3) adenocarcinomas

We selected 63 prostate tumors with Gleasons grade 6 (3+3), commonly showing both tubular and cribrous patterns. We compared in both patterns the expression of two of the most used biologic markers: PCNA and p53, with the aim to verify the validity of the Gleasons grading system to compare the morphologic grade with biologic aggressiveness and prognostic value. We did not find any statistical difference in the protein immunopositivity, indicating that both patterns could have identical biologic behaviour; then we confirmed the validity of Gleasons system for considering both tubular and cribrous patterns as an intermediate grade of tumoral differentiation. Moreover, we found a linear relationship between the increase of PCNA and the accumulation of mutated p53; this datum could confirm the hypothesis that p53 mutation is a late event in prostate carcinogenesis.

Rare localization of low-grade fibromyxoid sarcoma to the nail region.

1 Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localised vegetative form of pyoderma gangrenosum. J Am Acad Dermatol, 1988; 18:511–21. 2 Winkelmann RK, Wilson-Jones E, Gibson LE, Quimby SR. Histopathology features of superficial granulomatous pyoderma. J Dermatol, 1989; 16:127–32. 3 Lichter MD, Welykj SE, Gradini R, Solomon LM. Superficial granulomatous pyoderma. Int J Dermatol, 1991; 30:418–21. 4 Hardwick N, Cerio R. Superficial granulomatous pyoderma. A report of two cases. Br J Dermatol, 1993; 129:718–22. 5 Sadigh-Ershadi V, Bassi E, Borroni G et al. Pioderma gangrenoso granulomatoso superficiale: studio di un caso e revisione della letteratura. Boll Soc Med Chir Pavia, 2000; 114:145–52. 6 Check IJ, Ellington EP, Moreland A et al. T helper–suppressor cell imbalance in pyoderma gangrenosum, with relapsing polychondritis and corneal keratolysis. Am J Clin Pathol, 1983; 80:396–9. 7 Schroeter AL. Superficial granulomatous pyoderma. Mayo Clinic Proc, 1989; 64:123–4. 8 Hayes RC, Curtis A. Pyoderma gangrenosum with a contiguous erosion of the distal ulna. J Cutan Med Surg, 2004; 8:162–5. 9 Yoshida C, Kojima H, Ishigaki T. et al. Association of pyoderma gangrenosum and sterile osteomyelitis in a patient having myelodysplastic syndrome with der(1;7)(q10;q10). Eur J Haematol 2004; 72:149–53. 10 Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a paediatric patient. Pediatr Dermatol 1998, 2004; 15:435–8.

Difference in Ki67 and Thymidylate Synthase Expression in Primary Tumour Compared with Metastatic Nodes in Breast Cancer Patients

Breast cancer is a heterogeneous disease, so therapeutic predictive biological markers need to be identified. To date an accurate evaluation of predictive markers is mainly done at the primary site; however, the main goal of adjuvant therapy for breast cancer is the control of micrometastases. The aim of this study is to assess as therapeutic and/or prognostic marker, the proliferation status of primary tumors and involved nodes as measured by Ki67 and thymidylate synthase (TS) expression, in 30 breast cancer node positive patients. TS is the main target of 5-fluorouracil (5-FU) activity, and its overexpression is one of the mechanisms of 5-FU drug resistance; however, in some studies its absence is responsible for a worse response to 5-FU. Our results show that malignant cells of involved nodes were in a post mitotic phase of the cell cycle, and show a low proliferation index and TS expression, while the primary tumours and controls, were strongly positive. On these basis we can hypothesize that these cells could be less sensitive to 5-FU. Further studies are necessary to identify other mechanisms responsible for their metastasing capability and/or for their aggressiveness.

Clinical implications of a rare renal entity: Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)

Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare benign lesion characterized by slow growth, infiltrative behavior and high rate of local recurrences. Only one case has been described in retroperitoneum, at renal hilum, but not involving pelvis or parenchyma. Here we present the first case of PHAT arising in the renal parenchyma. A nodular lesion in right kidney lower pole was diagnosed to a 61 year old woman. The patient underwent right nephrectomy. Microscopically, the lesion showed solid and pseudo-cystic components with hemorrhagic areas characterized by aggregates of ectatic blood vessels. Pleomorphic cells were characterized by large eosinophilic cytoplasm with irregular and hyperchromatic nuclei. Immunohistochemistry was performed and the lesion was classified as a Pleomorphic Hyalinizing Angiectatic Tumor (PHAT). Due to the clinical behavior of this tumor, in spite of its benign nature, review of the surgical margins and close follow up after partial nephrectomy are mandatory.